Chronic liver injury during obstructive sleep apnea

Hepatology

Volumn 41, Issue 6, 2005, Pages 1290-1296

  Tanné, Florence ^a   Gagnadoux, Frédéric ^a   Chazouillères, Olivier ^a   Fleury, Bernard ^a   Wendum, Dominique ^a   Lasnier, Elisabeth ^a   Lebeau, Bernard ^a   Poupon, Raoul ^a,b   Serfaty, Lawrence ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIVER ENZYME;

ADULT; AGED; APNEA; ARTICLE; BODY MASS; CELL DEATH; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SLEEP APNEA SYNDROME;

ADULT; CHRONIC DISEASE; ENZYMES; FATTY LIVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; STAINING AND LABELING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20044378321     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20725     Document Type: Article

References (28)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
2. Strollo PJ, Rogers RM. Obstructive sleep apnea. N Engl J Med 1996;334:99-104.
3. Henrion J, Colin L, Schapira M, Heller FR. Hypoxie hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997;24:245-249.
4. Mathurin P, Durand F, Ganne N, Mollo JL, Lebrec D, Degott C, et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995;109:1682-1684.
5. Stoohs R, Facchini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 1996;154:170-174.
6. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-676.
7. Wilcox I, McNamara S, Collins F, Grunstein R, Sullivan C. "Syndrome Z": the interaction of sleep apnea, vascular risk factors and heart disease. Thorax 1998;53:S25-S28.
8. Brooks B, Cistulli P, Borkman M, Ross G, McGhee S, Grunstein R. Obstructive sleep apnea in obese non insulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994;79:1681-1685.
9. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1331-1333.
10. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003;136:167-178.
11. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and over-weight men. Am J Respir Crit Care Med 2002;165:677-682.
12. Poupon RE, Schellenberg F, Nalpas B, Weill J. Assessment of the transferrin index in screening heavy drinkers from a general practice. Alcohol Clin Exp Res 1989;13:549-553.
13. Fleury B, Rakotonanahary D, Petelle B, Vincent G, Pelletier Fleury N, Meyer B, et al. Mandibular advancement titration for obstructive sleep apnea: optimization of the procedure by combining clinical and oximetric parameters. Chest 2004;125:176l-1767.
14. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-482.
15. Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T, et al. Impaired glucose-insulin metabolism in males with obstructive sleep apoea syndrome. Eur Respir J 2003;22:1-5.
16. Vaubourdolle M, Chazouilleres O, Briaud I, Legendre C, Serfaty L, Poupon R, et al. Plasma alpha-glutathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis C. Clin Chem 1995;41:1716-1719.
17. Brunt E, Janney C, Di Bisceglie A, Neuschwander-Tetri B, Bacon B. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
18. Rigaud D. Abnormal liver tests and obesity: CAT. Act Med Int Gastroentérologie 1999;13:189-195.
19. Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, Masuzaki H. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003;114:370-376.
20. Garcia-Monzon C, Martin-Perez E, Lo Iacono O, Fernandez-Bermejo M, Majano P, Apolinario A, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 2000;33:716-724.
21. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
22. Sheth S, Gordon F, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-145.
23. Reid A. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710-723.
24. Tasali E, Van Cauter E. Sleep-disordered breathing and the current epidemic of obesity. Am J Respi Crit Care Med 2002;165:562-563.
25. Day C, James O. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-845.
26. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic Steatohepatitis: summary of an AASLD single topic conference. HEPATOLOGY 2003;37:1202-1219.
27. Chalasani N, Gorski CJ, Asghar MS, Asghar A, Foresman B, Hall SD, et al. Hepatic cytochrome P450 2E1 activity in non-diabetic patients with nonalcoholic Steatohepatitis. HEPATOLOGY 2003;37:544-550.
28. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15:551-578.